E25bio

Provider of diagnostic platform for disease mapping and detection

placeCambridge, Massachusetts, United States calendar_todayFounded 2018 groups5 employees language e25bio.com

Innovation

3 patent families — focus: Physics & computing, Chemistry & metallurgy; filing pace slowing. Cited 9 times.

YearFilings
20212
20221

Investor mix

8 investors on record; lead investors include Khosla Ventures, Engine.

Investor typeCountShare
Venture capital450%
Bank & private debt113%
Other / undisclosed338%
Coming soon